TRANSPOSAGEN BIOPHARMACEUTICALS, INC. SBIR Phase II Award,
A SBIR Phase II contract was awarded to TRANSPOSAGEN BIOPHARMACEUTICALS, INC. for $1,647,590.0 USD from the U.S. Department of Health & Human Services.
Is a
Award Amount (USD)
1,647,590
0
SBIR/STTR Award Recipient
Contract Number (US Government)
2R44RR025738-02
0
Award Phase
Phase II
0
Award Type
SBIR
0
Official Website
Find more entities like TRANSPOSAGEN BIOPHARMACEUTICALS, INC. SBIR Phase II Award,
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.